trial · primary record
Aflibercept
Macular Degeneration
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 84 |
| Primary completion | 2015-12 |
| Primary endpoint | Change From Baseline in Maximal Height of Pigment Epithelium Detachment (PED) at 12 Weeks |
| Registry ID | NCT02157077 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:45.907Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02157077
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.